Prevention of cardiovascular events with antiplatelet treatment: does time of intake matter for aspirin and ADP receptor blockers?

Thrombosis and Haemostasis
D SibbingD Aradi

Abstract

Long-term evidence supports a clustering of cardiovascular events in the early morning. Several studies have shown that platelet hyper-reactivity to various stimuli is also present at this period of the day. However, the idea of treatment strategies reflecting the circadian variation in platelet reactivity has been largely neglected so far, and this is true despite the huge number of patients being treated with these drugs. Some pharmacodynamic data suggest that early-morning platelet hyper-reactivity may be overcome by shifting aspirin intake to the bedtime. However, there is lack of evidence whether shifting the time of intake or splitting the daily dose of P2Y12-inhibitors with a regular QD dosing (clopidogrel or prasugrel) to the evening would be effective to overcome platelet hyper-reactivity or to suppress the excess of cardiovascular events observed during morning hours. Further research is warranted to clarify whether such a simple and costless effort like dose shifting or splitting may be beneficial to prevent cardiovascular events.

References

Apr 1, 1992·The American Journal of Cardiology·S M JafriS Goldstein
Oct 1, 1987·The American Journal of Cardiology·S N WillichJ E Muller
Jan 1, 1987·Circulation·J E MullerP H Stone
Sep 28, 2002·Journal of Cardiovascular Pharmacology·Mitsunori SawadaMitsuaki Isobe
Aug 16, 2005·The American Journal of Cardiology·Ildikó KriszbacherJózsef Bódis
Apr 8, 2006·Thrombosis and Haemostasis·Christina PernebyPaul Hjemdahl
Sep 1, 2009·The New England Journal of Medicine·Lars WallentinMona Thorsén
Mar 9, 2010·International Journal of Cardiology·Marie LordkipanidzéJean G Diodati
Sep 8, 2010·The New England Journal of Medicine·Shamir R MehtaSalim Yusuf
Nov 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Frank A J L ScheerSteven A Shea
Dec 8, 2010·Thrombosis and Haemostasis·Patrick HenryLudovic Drouet
Feb 26, 2011·JACC. Cardiovascular Interventions·Karim D MahmoudDavid R Holmes
Jun 2, 2011·Platelets·Marek KozinskiJacek Kubica
Nov 15, 2011·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Hideki ItayaMasato Nakamura
Nov 8, 2012·Chronobiology International·Owen MogabgabEugene Braunwald
Apr 13, 2013·Clinical Medicine & Research·Rajan KanthShereif Rezkalla
Sep 26, 2013·Journal of Cardiovascular Pharmacology and Therapeutics·Owen MogabgabRobert P Giugliano
Apr 22, 2014·Journal of the American College of Cardiology·Kristen K PattonUNKNOWN SCD-HeFT Investigators
May 28, 2014·International Journal of Cardiology·Morten WürtzErik L Grove
Nov 29, 2014·Journal of Cardiovascular Electrophysiology·Martin H RuwaldValentina Kutyifa
Mar 17, 2015·The New England Journal of Medicine·Marc P BonacaUNKNOWN PEGASUS-TIMI 54 Steering Committee and Investigators

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.